Two Directors at Calumet Inc sold 175,123 shares at between 15.847USD and 16.690USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grant of an option to purchase 75,000 shares of its common stock and restricted stock units coveri...
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair Based on market research, inguinal hernia repair is the most common type of hernia repair MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. T...
Moody's Ratings (Moody's) has assigned a Ba1 long-term senior unsecured rating to Rocket Companies, Inc.'s (Rocket) new $4.0 billion backed senior unsecured notes and affirmed Rocket Mortgage, LLC's Ba1 long-term senior unsecured rating. We have also assigned a Ba1 corporate family rating (CFR) to R...
TELA Bio Appoints Jeffrey Blizard as President Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Jeffrey Blizard as President of TELA Bio, effective immediately. Mr. Blizard, who has served on TELA Bio’s Board of Directors for the past year, brings deep industry experience and proven leadership to this expanded role. “...
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 Jefferies Global Healthcare Conference. TELA’s management is scheduled to present at the 2025 Jefferies Global Healthcare Conference at 11:05 am ET on June 5th, 2025. Interested parties can access the live and archived webcast at . About TELA Bio, Inc.TELA Bio, ...
Middlefield Banc Corp. Announces Retirement of Darryl E. Mast from Board of Directors MIDDLEFIELD, Ohio, May 22, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced the retirement of Darryl E. Mast from its Board of Directors, effective May 14, 2025. Mr. Mast joined the Middlefield Banking Company’s Board of Directors in 2011 and has been a Director of Middlefield Banc Corp. since 2013. His leadership, insight, and expertise have been integral to the success of Middlefield Banc Corp. and The Middlefield Banking Company, and his contributions have left a lasting...
Synaptics Names Rahul Patel as President and Chief Executive Officer Semiconductor industry executive with experience at Qualcomm and Broadcom to drive company’s next chapter of innovation and growth in Processing, Connectivity, and Sensing SAN JOSE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) announced today that Rahul Patel has been appointed President and Chief Executive Officer, and a Director of the company. Patel succeeds Synaptics CFO Ken Rizvi, who has served as the company’s Interim CEO since February 2025. Rizvi will continue to serve as the com...
Conifer Holdings Reports 2025 First Quarter Financial Results TROY, Mich., May 14, 2025 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Personal Lines production was up 22% for the periodNet income allocable to common shareholders of $522,000, or $0.04 per shareBook value increased to $2.09 per common share outstanding Management Comments Brian Roney, CEO of Conifer, commented, "While we were pleased to see continued growth in our Persona...
Middlefield Banc Corp. Announces 2025 Second-Quarter Cash Dividend Payment MIDDLEFIELD, Ohio, May 12, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.21 per common share. The 2025 second-quarter dividend is payable on June 13, 2025, to shareholders of record on May 30, 2025. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the Bank holding Company of The Middlefield Banking Company, with total assets of $1.89 billion at March 31, 2025. The Bank op...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 6,600 shares of its common stock to twelve newly-hired employees, with a grant date of May 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuan...
Synaptics Announces Fiscal Fourth Quarter 2025 Investor Conference Participation SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in the following investor conferences in the fiscal fourth quarter of 2025: Ken Rizvi, Interim CEO and Chief Financial Officer, will present at the J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference on Tuesday, May 13, 2024, at 6:30 AM PT. To view the webcast or access a replay, please visit Ken Rizvi, Interim CEO and Chief Financial Officer, will participate in ...
TELA Bio Reports First Quarter 2025 Financial Results MALVERN, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Delivered revenue of $18.5 million in the first quarter 2025, representing growth of 12% over the prior year period and sequential growth of 5% over the fourth quarter of 2024;Increased demand for OviTex® and OviTex PRS Reinforced Tissue Matrix product...
Synaptics Reports Third Quarter Fiscal 2025 Results Quarterly revenues increased 12% year-over-year, driven by a 43% growth in Core IoT product sales Q3’25 Financial Results Revenue of $266.6 millionGAAP gross margin of 43.4%Non-GAAP gross margin of 53.5%GAAP loss per share of $0.56Non-GAAP diluted earnings per share of $0.90Repurchased approximately 546,000 shares for $37.9 million SAN JOSE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: ) today reported financial results for its third quarter of fiscal 2025 ended March 29, 2025. Net revenue...
Synaptics and Murata Partner for Next-Generation Automotive Wireless Connectivity To jointly develop a turnkey module for automotive Tier 1 suppliers and OEMs using Synaptics’ highly integrated Wi-Fi® and Bluetooth® combo SoCs SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) and Murata Manufacturing today announced they are partnering to develop a next-generation turnkey wireless connectivity module for automotive Tier 1 suppliers and OEMs. Through this partnership, Synaptics’ ™ Wi-Fi and Bluetooth combo systems on chips (SoCs)—featuring highly integ...
American Assets Trust, Inc. Reports First Quarter 2025 Financial Results Net income available to common stockholders of $42.5 million for the first quarter, or $0.70 per diluted share. Funds from Operations ("FFO") per diluted share excluding lease termination fees and litigation income decreased 10% year-over-year for the first quarter to $0.52 per diluted share. SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “company”) today reported financial results for its first quarter ended March 31, 2025. First Quarter Highlights Net income availabl...
Synaptics Unveils First Veros™ Wi-Fi 7 Family Tailored for the IoT Wi-Fi, Bluetooth, and Zigbee/Thread combo SoCs support high peak speed and low latency for gaming, AR/VR, entertainment, security, and automotive applications. SAN JOSE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) announced it has extended its wireless portfolio with its first family of Wi-Fi® 7 systems-on-chips (SoCs) tailored for the Internet of Things (IoT). Comprising the SYN4390 and SYN4384, the scalable offering supports bandwidths up to 320 MHz to deliver 5.8 Gbps peak speed and ...
Middlefield Banc Corp. Reports 2025 Three-Month Financial Results MIDDLEFIELD, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the three months ended March 31, 2025. 2025 Three-Month Financial Highlights (on a year-over-year basis): ●Earnings per share increased 17.6% year-over-year to $0.60 per diluted share ●Net interest margin expanded 15 basis points to 3.69% ●Return on average assets (annualized) increased 12 basis points year-over-year to 1.04% ●Asset quality improved from the 2024 fourth quarter with nonperformin...
Donegal Group Inc. Announces First Quarter 2025 Results MARIETTA, Pa., April 24, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the first quarter of 2025. Significant Items for First Quarter of 2025 (all comparisons to first quarter of 2024): Net premiums earned increased 2.2% to $232.7 millionCombined ratio of 91.6%, compared to 102.4%Net income of $25.2 million, or $0.71 per diluted Class A share, compared to $6.0 million, or $0.18 per diluted Class A shareNet investment losses (after tax) of $0.4 million, or 1 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.